104 related articles for article (PubMed ID: 18084118)
21. Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis.
Lems WF; Gerrits MI; Jacobs JW; van Vugt RM; van Rijn HJ; Bijlsma JW
Ann Rheum Dis; 1996 May; 55(5):288-93. PubMed ID: 8660101
[TBL] [Abstract][Full Text] [Related]
22. Rosuvastatin increased serum osteocalcin levels independent of its serum cholesterol-lowering effect in patients with type 2 diabetes and hypercholesterolemia.
Kanazawa I; Yamaguchi T; Yamauchi M; Sugimoto T
Intern Med; 2009; 48(21):1869-73. PubMed ID: 19881236
[TBL] [Abstract][Full Text] [Related]
23. [Bone metabolic marker for osteoporosis].
Shidara K; Inaba M
Nihon Rinsho; 2009 May; 67(5):927-31. PubMed ID: 19432111
[TBL] [Abstract][Full Text] [Related]
24. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
[TBL] [Abstract][Full Text] [Related]
25. Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastases.
Nishimukai A; Higuchi T; Ozawa H; Yanai A; Miyagawa Y; Murase K; Imamura M; Takatsuka Y; Miyoshi Y
Breast Cancer; 2017 Mar; 24(2):245-253. PubMed ID: 27040403
[TBL] [Abstract][Full Text] [Related]
26. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
Marcus R; Holloway L; Wells B; Greendale G; James MK; Wasilauskas C; Kelaghan J
J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288
[TBL] [Abstract][Full Text] [Related]
27. Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastases.
Morris PG; Fazio M; Farooki A; Estilo C; Mallam D; Conlin A; Patil S; Fleisher M; Cremers S; Huryn J; Hudis CA; Fornier MN
J Oral Maxillofac Surg; 2012 Dec; 70(12):2768-75. PubMed ID: 22330331
[TBL] [Abstract][Full Text] [Related]
28. Relationships between serum adiponectin, leptin concentrations and bone mineral density, and bone biochemical markers in Chinese women.
Wu N; Wang QP; Li H; Wu XP; Sun ZQ; Luo XH
Clin Chim Acta; 2010 May; 411(9-10):771-5. PubMed ID: 20184866
[TBL] [Abstract][Full Text] [Related]
29. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the acute alterations in serum bone turnover markers and bone mineral density among women with surgical menopause.
Bahar S; Abali R; Guzel S; Bozkurt S; Guzel EC; Aral H; Boran AB
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):194-7. PubMed ID: 21764505
[TBL] [Abstract][Full Text] [Related]
31. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.
Chaki O; Yoshikata I; Kikuchi R; Nakayama M; Uchiyama Y; Hirahara F; Gorai I
J Bone Miner Res; 2000 Aug; 15(8):1537-44. PubMed ID: 10934652
[TBL] [Abstract][Full Text] [Related]
32. Comparison of two bone markers with growth evolution in 74 girls with central precocious puberty.
Vincent A; Souberbielle JC; Brauner R
BMC Pediatr; 2018 Jul; 18(1):224. PubMed ID: 29986677
[TBL] [Abstract][Full Text] [Related]
33. Short-term vitamin A supplementation does not affect bone turnover in men.
Kawahara TN; Krueger DC; Engelke JA; Harke JM; Binkley NC
J Nutr; 2002 Jun; 132(6):1169-72. PubMed ID: 12042428
[TBL] [Abstract][Full Text] [Related]
34. Bone turnover in preeclampsia-complicated pregnancy in North Indian women.
Kumar A; Devi SG; Prasad S; Kapoor S; Sharma S
J Obstet Gynaecol Res; 2012 Jan; 38(1):172-9. PubMed ID: 21995528
[TBL] [Abstract][Full Text] [Related]
35. The effect of methotrexate on bone metabolism markers in patients with rheumatoid arthritis.
Torikai E; Kageyama Y; Takahashi M; Nagano A
Mod Rheumatol; 2006; 16(6):350-4. PubMed ID: 17164995
[TBL] [Abstract][Full Text] [Related]
36. Reference intervals for serum concentrations of three bone turnover markers for men and women.
Michelsen J; Wallaschofski H; Friedrich N; Spielhagen C; Rettig R; Ittermann T; Nauck M; Hannemann A
Bone; 2013 Dec; 57(2):399-404. PubMed ID: 24076251
[TBL] [Abstract][Full Text] [Related]
37. A randomized clinical trial of the effects of isosorbide mononitrate on bone formation and resorption in post-menopausal women: a pilot study.
Nabhan AF
Hum Reprod; 2006 May; 21(5):1320-4. PubMed ID: 16410328
[TBL] [Abstract][Full Text] [Related]
38. A phase 3, double-blind, randomised, parallel-group, placebo-controlled study of oral weekly alendronate for the prevention of androgen deprivation bone loss in nonmetastatic prostate cancer: the Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) study.
Klotz LH; McNeill IY; Kebabdjian M; Zhang L; Chin JL;
Eur Urol; 2013 May; 63(5):927-35. PubMed ID: 23040208
[TBL] [Abstract][Full Text] [Related]
39. Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women.
Berthold HK; Unverdorben S; Zittermann A; Degenhardt R; Baumeister B; Unverdorben M; Krone W; Vetter H; Gouni-Berthold I
Osteoporos Int; 2004 Jun; 15(6):459-67. PubMed ID: 15205717
[TBL] [Abstract][Full Text] [Related]
40. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
Heikkinen AM; Parviainen M; Niskanen L; Komulainen M; Tuppurainen MT; Kröger H; Saarikoski S
J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
